11.04.2023
opracowała: dr n. med. Weronika Rymer
1. Raccagni A.R. i wsp.: Meningococcus B Vaccination Effectiveness against Neisseria gonorrhoeae Infection in People Living with HIV: a Case-control Study. Sex Transm. Dis. 2023 Jan 13. doi: 10.1097/OLQ.0000000000001771.
2. Thng C. i wsp.: An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol. BMC Public Health. 2023 Mar 30;23(1): 607. doi: 10.1